- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02809846
Quell Opioid Reduction and Pain Relief in Patients With Cancer
January 9, 2020 updated by: Scripps Translational Science Institute
To study effects the Quell device has on opioid consumption and pain relief in patients with cancer.
Study Overview
Status
Terminated
Intervention / Treatment
Detailed Description
Single site, double blinded, placebo controlled randomized clinical trial.
40 subjects will be selected based on the inclusion criteria and then randomized to either the intervention group or the placebo control group.
Prior to the start of this study, a Controlled Substance Utilization Review and Evaluation (CURES) reports will be acquired to establish baseline number of opioid prescriptions for each subject.
Subjects will track how consistently they are using pain medications, both opioids and non-opioids, during the two weeks prior to the start of the study.
They will also provide twice daily recordings of their pain intensity via a mobile application.
At the end of this two-week period, each subject will be fitted with a Quell device or a sham device, including initial calibration to the subject's comfort level as described in the background section.Once the study subjects have started using the device, we will also be able to monitor and track their sleep wirelessly via the mobile application as long as they are wearing the device.
Subjects will receive weekly check in's to monitor the functionality of the device and to help troubleshoot any issues with the device for the duration of subject participation in the study.
These check-ins will take place in person, by phone, and or per subject's usual outpatient oncology visits.
Each subject will use their device for 8 weeks, during which they will continue to track their pain, sleep and frequency of pain medication use as stated above.
Study investigators will receive automated alerts via email to ensure that study are participants using their devices and that the devices are powered on at regular intervals for the duration of the study.Total duration of subject participation will be 10 weeks.
Study Type
Interventional
Enrollment (Actual)
33
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
La Jolla, California, United States, 92037
- Scripps Translational Science Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or Female greater than or equal to 18 year of age at visit one.
- Documented diagnosis of metastatic breast, prostate or colorectal cancer with a prognosis of 6 month or greater as determined by the primary oncologist.
- Visual evidence that subject owns a smart phone and is able to use basic mobile applications such as downloading an app, opening the app, and performing one simple task within the app.
- Subject speaks and reads English fluently.
- Subject able to understand and grant informed consent.
- Live in an area with cellular data connectivity available as provided by the subject.
- Documented adherence with clinic follow up visits per medical records.
- Subject using at least one opioid medication on a daily basis.
Exclusion Criteria:
- Subject has a cardiac pacemaker, implanted defibrillator or other implanted electronic device.
- Inability to complete subjective data as required; e.g. on mobile application and questionnaires.
- Does not live in an area with suitable cellular data connectivity.
- Has infrequent scheduled clinic visits.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Quell Device
Quell is a class II medical device with FDA 510(k) clearance for the symptomatic relief and management of chronic intractable pain, without a prescription.
It operates by using an electrical stimulator to activate peripheral sensory nerves and trigger analgesia.
|
|
Sham Comparator: Sham Quell Device
Identical to Active Comparator, but provides sub-therapeutic electronic stimulation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Daily Opioid Use Assessed as Recorded by the Subject in Their Analgesia Diary.
Time Frame: Weeks: 2,4,6,8,10
|
The primary end point of this study was the difference in the change in daily opioid use between the active device group and the sham device group, assessed at weeks 2, 4, 6, 8, and 10 of the study as recorded by the subject in their analgesia diary.
Participants documented which medication was taken, how much, and at what time.
Dose and type of opioid pain medication was converted to morphine milliequivalents (MME) using conversion factors published by the Centers for Medicare and Medicaid Services (CMS)and combined as a daily dose for each day in a subject's analgesia journal.
|
Weeks: 2,4,6,8,10
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Lase Ajayi, MD, Scripps
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2016
Primary Completion (Actual)
August 1, 2017
Study Completion (Actual)
October 1, 2017
Study Registration Dates
First Submitted
June 20, 2016
First Submitted That Met QC Criteria
June 21, 2016
First Posted (Estimate)
June 22, 2016
Study Record Updates
Last Update Posted (Actual)
January 21, 2020
Last Update Submitted That Met QC Criteria
January 9, 2020
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-16-6815
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
Clinical Trials on Quell
-
Brigham and Women's HospitalCompleted
-
Brigham and Women's HospitalNeuroMetrix, Inc.RecruitingHypersensitivity | Chronic Pain | Adults 21 and Older | Multiple Chronic Overlapping Pain ConditionsUnited States
-
Brigham and Women's HospitalCompleted